HDAC3 and inflammatory bowel disease: Recent studies implicated particular HDAC isoforms, HDAC2, HDAC3, HDAC6, HDAC9, and HDAC10, in chronic intestinal inflammation and, thus, selective HDACis serve as attractive therapeutic options for IBD [22,25,28,34,35].